p53 Aggregation: Its Mechanics and Potential Contribution to the Development of Alzheimer’s Disease (#41)
David Lynch
1
2
,
Madeline Demny
3
4
,
Nemil Bhatt
1
2
,
Nikita Shchankin
1
2
,
Sangho Yun
5
,
Arthur Laganowsky
5
,
Phanourios Tamamis
3
4
,
Rakez Kayed
1
2
- University of Texas Medical Branch, Galveston, TEXAS, United States
- Mitchell Center for Neurodegenerative Diseases, University of Texas Medical Branch, Galveston, Texas, United States
- Chemical Engineering, Texas A&M University, College Station, Texas, United States
- Materials Science and Engineering, Texas A&M University, College Station, Texas, United States
- Chemistry, Texas A&M University, College Station, Texas, USA
Publish consent withheld
- Feroz, W., & Sheikh, A. M. A. (2020). Exploring the multiple roles of guardian of the genome: P53. Egyptian Journal of Medical Human Genetics, 21(1), 49
- Farmer, K. M., Ghag, G., Puangmalai, N., Montalbano, M., Bhatt, N., & Kayed, R. (2020). P53 aggregation, interactions with tau, and impaired DNA damage response in Alzheimer’s disease. Acta neuropathologica communications, 8(1), 132.
- Chang, J. R., Ghafouri, M., Mukerjee, R., Bagashev, A., Chabrashvili, T., & Sawaya, B. E. (2012). Role of p53 in neurodegenerative diseases. Neurodegenerative Diseases, 9(2), 68-80
- Uversky, V. N. (2016). p53 proteoforms and intrinsic disorder: An illustration of the protein structure–function continuum concept. International journal of molecular sciences, 17(11), 1874.